AQR Arbitrage’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-41,347
Closed -$430K 1080
2022
Q4
$430K Hold
41,347
0.01% 617
2022
Q3
$421K Hold
41,347
0.01% 707
2022
Q2
$420K Hold
41,347
0.01% 708
2022
Q1
$416K Sell
41,347
-58,649
-59% -$588K 0.01% 633
2021
Q4
$999K Buy
+99,996
New +$998K 0.03% 623

Other funds holding OCEA

AQR Arbitrage's OCEA Position: Q1 2023 in Review

AQR Arbitrage sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2023, closing a stake of 41,347 shares — an estimated $430K sold.

AQR Arbitrage first reported a position in OCEA in Q4 2021 and held it in 5 quarters. The position peaked at $999K in Q4 2021. 17 funds tracked by Wall St. Rank hold OCEA as of Q1 2023.

  • AQR Arbitrage reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • AQR Arbitrage sold 41,347 Ocean Biomedical, Inc. Common Stock shares in Q1 2023, an estimated $430K.
  • AQR Arbitrage first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • AQR Arbitrage's Ocean Biomedical, Inc. Common Stock position peaked at $999K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2023.

Based on AQR Arbitrage's 13F filing for Q1 2023, filed 15 May 2023.